Gemcitabine Plus Cisplatin in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Is Recurrent or Has Not Responded to Platinum-based Chemotherapy
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Cheryl A. Brewer, MD
University of Illinois College of Medicine at Peoria
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
31 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Norwegian Radium Hospital
Oslo, Norway
- Community Hospital of Los Gatos
Los Gatos, California, United States
- H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
- Rush-Presbyterian-St. Luke'S Medical Center
Chicago, Illinois, United States
- University of Chicago Cancer Research Center
Chicago, Illinois, United States
- Ellis Fischel Cancer Center
Indianapolis, Indiana, United States
- Indiana University Cancer Center
Indianapolis, Indiana, United States
- Holden Comprehensive Cancer Center
Iowa City, Iowa, United States
- Warren Grant Magnuson Clinical Center - Nci Clinical Studies Support
Bethesda, Maryland, United States
- Tuft-New England Medical Center
Boston, Massachusetts, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- Ellis Fischel Cancer Center - Columbia
Columbia, Missouri, United States
- Cooper Hospital/university Medical Center
Camden, New Jersey, United States
- State University of New York Health Science Center at Brooklyn
Brooklyn, New York, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- State University of New York Health Sciences Center - Stony Brook
Stony Brook, New York, United States
- Lineberger Comprehensive Cancer Center, Unc
Chapel Hill, North Carolina, United States
- Duke Comprehensive Cancer Center
Durham, North Carolina, United States
- Comprehensive Cancer Center at Wake Forest University
Winston-Salem, North Carolina, United States
- Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, United States
- Ireland Cancer Center
Cleveland, Ohio, United States
- University of Oklahoma College of Medicine
Oklahoma City, Oklahoma, United States
- Abington Memorial Hospital
Abington, Pennsylvania, United States
- Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- University of Pennsylvania Cancer Center
Philadelphia, Pennsylvania, United States
- Brookview Research, Inc.
Nashville, Tennessee, United States
- Simmons Cancer Center - Dallas
Dallas, Texas, United States
- University of Texas Medical Branch
Galveston, Texas, United States
- Ccop - M.D. Anderson Research Base
Houston, Texas, United States
- University of Wisconsin Comprehensive Cancer Center
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2001
- Primary completion
- 31 Jan 2007
- Completion
- —
- Last update posted
- 27 May 2013
- Registered enrollment
- —
- Registry id
- NCT00006028
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.